99mTechnetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 8, 2010, Pages 1006-1012

  El Shabrawi, Mortada Hassan ^a   Omran, Salwa ^a   Wageeh, Shereine ^a   Isa, Mona ^a   Okasha, Sawsan ^a   Mohsen, Nabil A ^a   Zekry, Ola ^a   E Bartan, Gamal ^a   El Karaksy, Hanaa M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

99mTc MAA scan; chronic liver disease; contrast enhanced echocardiography; hepatopulmonary syndrome; intrapulmonary shunts

Indexed keywords

ALBUMIN; OXYGEN; SODIUM CHLORIDE; TECHNETIUM 99M; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT;

AMBIENT AIR; ARTICLE; BLOOD GAS; CHILD; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EGYPT; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; INBORN ERROR OF METABOLISM; LIVER CIRRHOSIS; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PULMONARY SHUNT; RATING SCALE; SCHISTOSOMIASIS; SCHOOL CHILD; SHUNTING; THORAX; VIRUS INFECTION; ANOXIA; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; DIAGNOSTIC USE; ECHOGRAPHY; HEPATITIS B; HEPATITIS C; LUNG CIRCULATION; PROCEDURES; SCINTIGRAPHY; SCINTISCANNING;

ANOXIA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATOPULMONARY SYNDROME; HUMANS; LIVER CIRRHOSIS; MALE; METABOLISM, INBORN ERRORS; PERFUSION IMAGING; PULMONARY CIRCULATION; RADIOPHARMACEUTICALS; SCHISTOSOMIASIS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 77955218148     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328336562e     Document Type: Article

References (24)

1. Przybyowski T, Krenke R, Fangrat A, Nasilowski J, Grabczak EM, Styczynskg G, et al. Gas exchange abnormalities in patients listed for liver transplantation. J Physiol pharmacol 2006; 57:313-323.
2. Schenk P. The hepatopulmonary syndrome. Eur Resp Mon 2006; 34:112-128.
3. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic disease. Hepatology 2000; 32:859-865.
4. Flükiger M. Occurrence of club-shaped finger phalanges without chronic changes in the lungs or heart. Wien Med Wochenschr 1884; 34:1457-1458.
5. Kenedy TC, Knudson RJ. Exercise-aggravated hypoaxemia and orthodeoxia in cirrhosis. Chest 1977; 2:305-309.
6. Mazzeo AT, Lucanto T, Santamaria LB. Hepatopulmonary syndrome: a concern for the anesthetist? Pre-operative evaluation of hypoxemic patients with liver disease. Acta Anaesth Scand 2004; 48:178-186.
7. Ho V. Current concepts in management of hepatopulmonary syndrome. Vasc Health Risk Manage 2008; 4:1035-1041.
8. Gomez FP, Barberà JA, Roca J, Burgos F, Gistau C, Rodrìguez-Roisin RE. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 2006; 43:1084-1091.
9. Gupta NA, Abramowsky C, Pillen T, Redd D, Fasola C, Heffron T, et al. Pediatric hepatopulmonarys Syndrome is seen with polysplenia/ interrupted inferior vena cava and without cirrhosis. Liver Transpl 2007; 13:680-686.
10. Swanson KL,Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Heptaology 2005; 41:1122-1129.
11. Noli K, Solomon M, Golding F, Charron F, Ling SC. Prevalence of hepatopulmonary syndrome in children. Pediatrics 2008; 121:e522-e527.
12. Wolfe JD, Tashkin DP, Holly EF. Hypoxemia of cirrhosis, detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method. Am J Med 1977; 63:746-754.
13. Mahmoodi E, Kianifar HR, Partovi S, Mafinejad S, Bozorgnia A. Intrapulmonary arteriovenous shunt in children with chronic liver disease: clinical features, laboratory outcome. Indian J Gastroenterol 2008; 27:16-18.
14. Rodrìguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24:861-880.
15. Thorens E, Junod AF. Hypoxaemia and liver cirrhosis: a new argument in favor of a diffuse perfusion defect. Eur Respir J 1992; 5:754-756.
16. Deibert P, Allgaier HP, Loesch S, Müller C, Olschewski M, Hamm H, et al. Heptaopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry. BMC Gastroenterol 2006; 6:15.
17. Scott VL, Dodson SF, Kany Y. The hepatopulmonary syndrome. Surg Clin North Am 1999; 79:23-41.
18. Wang YW, Lin HC. Recent advances in hepatopulmonary syndrome. J Chin Med assoc 2005; 68:500-568.
19. Aboussouan LS, Stoller JK. The hepatopulmonary syndrome. Baillieres Best Pract Res Clin Gastroenterol 2000; 14:1033-1048.
20. Lu W, Lu G, Zhu Y. The value of dynamic pulmonary perfusion imaging in the diagnosis of hepatopul-monary syndrome. Zhonghua Ju He He Hu Xi Za Zhi 2001; 19:219-221.
21. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109:1283-1288.
22. Culafic DJ, Perisic M, Rebic P. Hepatopulmonary syndrome in liver cirrhosis. Sp Arh Med Lec 2000; 128:271-275.
23. Zhang H, Bai C,Wang J, Han G, Gvo X, Zhou X, et al. Significance of lung perfusion scanning with Tc 99m MAA and pulmonary function assay for diagnosis of early hepatopulmonary syndrome. Zhonghua Gan Zang Bing Za Zhi 2001; 9:331-333.
24. Krowka MJ,Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO2 response to 100% oxygen and brain uptake after 99mTc-MAA lung scanning. Chest 2000; 118:615-624.